CD63 Antibody Market was valued at USD 0.45 Billion in 2022 and is projected to reach USD 0.78 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030.
Despite the market's steady growth between 2018 and 2022, the demand for CD63 antibodies is poised for an even greater surge in the period from 2023 to 2033. As the global healthcare sector evolves, CD63 antibodies have found an expanded range of applications, particularly in immuno-oncology and immunotherapy. The increasing focus on personalized treatments and immunotherapies is expected to boost the demand for these antibodies over the next decade. Additionally, the integration of AI and biotechnology in drug discovery and development will likely expedite the commercialization of new CD63 antibody-based products, further contributing to the market's growth.
Driven by technological advancements, significant investments in research, and increasing clinical trials exploring novel applications, the demand for CD63 antibodies is projected to increase significantly by 2033. Market players are also focusing on strategic collaborations and partnerships to enhance their product portfolios and capture a larger share of the growing market. Moreover, the rising prevalence of diseases that require antibody-based treatments, especially within the aging global population, is expected to drive the market further.
Get an In-Depth Research Analysis of the Global CD63 Antibody Market Size And Forecast [2025-2032]
The CD63 Antibody market, spanning from 2018 to 2022, has experienced substantial growth due to the increased adoption of antibodies in medical research, diagnostics, and therapeutic treatments. The market’s expansion was largely driven by the escalating prevalence of various diseases, including cancers, cardiovascular disorders, and autoimmune diseases, where CD63 antibodies play a critical role in identifying and treating these conditions. In addition, advancements in antibody-based therapies, as well as rising demand for precision medicine, have significantly impacted market dynamics over the last five years. During this period, the global market witnessed considerable investments in research and development, leading to the launch of novel antibody-based diagnostic tools and therapeutic agents.
Merck
Thermo Fisher Scientific
NSJ Bioreagents
LifeSpan BioSciences
Bioss
GeneTex
BioLegend
Leading Biology
RayBiotech
OriGene Technologies
Abnova Corporation
Abbexa
ProSci
Bio-Rad
EpiGentek
HUABIO
R and D Systems
BosterBio
Cell Signaling Technology
Novus Biologicals
Biobyt
Jingjie PTM BioLab
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global CD63 Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global CD63 Antibody Market
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Based on Types the Market is categorized into Below types that held the largest CD63 Antibody market share In 2023.
Monoclonal
Polyclonal
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ CD63 Antibody Market Research Analysis
1. Introduction of the Global CD63 Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global CD63 Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global CD63 Antibody Market, By Type
6. Global CD63 Antibody Market, By Application
7. Global CD63 Antibody Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global CD63 Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/